" Receptor Radionuclide Therapy With 177Lu-DOTATOC
Conditions: Neuroendocrine Tumors; Paraganglioma; Pheochromocytoma Intervention: Drug: 177Lu-DOTATOC Sponsor: Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials